The Role of Bronchoscopic Surveillance Monitoring in the Care of Lung Transplant Recipients

Allan R. Glanville

doi:10.1055/s-2006-954606

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2006; 27(5): 480-491
DOI: 10.1055/s-2006-954606

The Role of Bronchoscopic Surveillance Monitoring in the Care of Lung Transplant Recipients

Allan R. Glanville¹

¹The Lung Transplant Unit, St. Vincent's Hospital, Sydney, Australia

Abstract

ABSTRACT

Fiberoptic bronchoscopy remains the gold standard to establish the presence or absence of acute pulmonary allograft rejection or infection after lung transplantation (LT). Performance of clinically mandated transbronchial lung biopsy enhances diagnostic precision and has a satisfactory risk:benefit ratio in experienced hands. Surveillance transbronchial biopsies have a lower yield but may provide longitudinal insight into immunological events in the allograft that can assist long-term management. Moreover, knowledge about the structural integrity of the bronchial anastomosis is critical to achieve optimum outcomes. Obliterative bronchiolitis (OB) is the most common cause of late graft dysfunction and mortality after LT. Significant OB is invariably associated with reduced graft function, denoted physiologically by the bronchiolitis obliterans syndrome (BOS). Importantly, not all BOS is due to OB. The major risk factor for BOS is thought to be acute cellular rejection but new data support an important role for lymphocytic bronchiolitis. This review examines the role of fiberoptic bronchoscopy after LT as a surveillance tool and discusses indications, risk:benefit, and outcomes, with emphasis on two specific findings on biopsy; namely, minimal acute cellular rejection and lymphocytic bronchiolitis. Findings on follow-up biopsies to assess the outcome of therapies and the natural history of untreated “minimal” rejection events are also discussed.

KEYWORDS

Lung transplantation - bronchoscopy - monitoring

Volltext

Referenzen

REFERENCES

1 Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation. 1988; 46 532-539
2 Hutter J A, Despins P, Higenbottam T, Stewart S, Wallwork J. Heart-lung transplantation: better use of resources. Am J Med. 1988; 85 4-11
3 Magro C M, Klinger D M, Adams P W et al.. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003; 3 1264-1272
4 Magro C M, Ross Jr P, Kelsey M, Waldman W J, Pope-Harman A. Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant. 2003; 3 1155-1166
5 Magro C M, Abbas A E, Seilstad K, Pope-Harman A L, Nadasdy T, Ross Jr P. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006; 67 274-283
6 Aboyoun C L, Tamm M, Chhajed P N et al.. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection. Am J Respir Crit Care Med. 2001; 164 460-463
7 Hopkins P M, Aboyoun C L, Chhajed P N et al.. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant. 2002; 21 1062-1067
8 Standardization of spirometry: 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987; 136 1285-1298
9 Estenne M, Maurer J R, Boehler A et al.. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002; 21 297-310
10 Chhajed P N, Aboyoun C, Chhajed T P et al.. Sedative drug requirements during bronchoscopy are higher in cystic fibrosis after lung transplantation. Transplantation. 2005; 80 1081-1085
11 Chhajed P N, Aboyoun C, Malouf M A et al.. Management of acute hypoxemia during flexible bronchoscopy with insertion of a nasopharyngeal tube in lung transplant recipients. Chest. 2002; 121 1350-1354
12 Chhajed P N, Aboyoun C, Malouf M A et al.. Prophylactic nasopharyngeal tube insertion prevents acute hypoxaemia due to upper-airway obstruction during flexible bronchoscopy. Intern Med J. 2003; 33 317-318
13 Chan C C, Abi-Saleh W J, Arroliga A C et al.. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant. 1996; 15 196-205
14 Chhajed P N, Aboyoun C, Malouf M A, Hopkins P M, Plit M L, Glanville A R. Risk factors and management of bleeding associated with transbronchial lung biopsy in lung transplant recipients. J Heart Lung Transplant. 2003; 22 195-197
15 Bjortuft O, Brosstad F, Boe J. Bronchoscopy with transbronchial biopsies: measurement of bleeding volume and evaluation of the predictive value of coagulation tests. Eur Respir J. 1998; 12 1025-1027
16 Kukafka D S, O'Brien G M, Furukawa S, Criner G J. Surveillance bronchoscopy in lung transplant recipients. Chest. 1997; 111 377-381
17 Scott J P, Fradet G, Smyth R L et al.. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant. 1991; 10(5 Pt 1) 626-636 discussion 636-637
18 Vitulo P, Cremaschi P, Arbustini E et al.. Surveillance transbronchial biopsy in the diagnosis of acute lung rejection in heart and lung and lung transplant recipients. Monaldi Arch Chest Dis. 1996; 51 12-15
19 Heurlin N, Lonnqvist B, Tollemar J, Ehrnst A. Fiberoptic bronchoscopy for diagnosis of opportunistic pulmonary infections after bone marrow transplantation. Scand J Infect Dis. 1989; 21 359-366
20 Guilinger R A, Paradis I L, Dauber J H et al.. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med. 1995; 152(6 Pt 1) 2037-2043
21 Girgis R E, Reichenspurner H, Robbins R C, Reitz B A, Theodore J. The utility of annual surveillance bronchoscopy in heart-lung transplant recipients. Transplantation. 1995; 60 1458-1461
22 Tiroke A H, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant. 1999; 13 131-157
23 Baz M A, Layish D T, Govert J A et al.. Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest. 1996; 110 84-88
24 Chemaly R F, Yen-Lieberman B, Castilla E A et al.. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol. 2004; 42 2168-2172
25 Baz M A, Ghio A J, Roggli V L, Tapson V F, Piantadosi C A. Iron accumulation in lung allografts after transplantation. Chest. 1997; 112 435-439
26 Cahill B C, Hibbs J R, Savik K et al.. Aspergillus airway colonization and invasive disease after lung transplantation. Chest. 1997; 112 1160-1164
27 Dosanjh A K, Elashoff D, Kawalek A, Moss R B, Esrig S. Activation of eosinophils in the airways of lung transplantation patients. Chest. 1997; 112 1180-1183
28 Henke J A, Golden J A, Yelin E H, Keith F A, Blanc P D. Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant. Chest. 1999; 115 403-409
29 Riise G C, Williams A, Kjellstrom C, Schersten H, Andersson B A, Kelly F J. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J. 1998; 12 82-88
30 Zheng L, Walters E H, Ward C et al.. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax. 2000; 55 53-59
31 Yousem S A, Berry G J, Brunt E M et al.. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990; 9 593-601
32 Trulock E P, Ettinger N A, Brunt E M, Pasque M K, Kaiser L R, Cooper J D. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest. 1992; 102 1049-1054
33 Tazelaar H D, Nilsson F N, Rinaldi M, Murtaugh P, McDougall J C, McGregor C G. The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection. J Thorac Cardiovasc Surg. 1993; 105 674-678
34 Flint A, Frank T S. Cytomegalovirus detection in lung transplant biopsy samples by polymerase chain reaction. J Heart Lung Transplant. 1994; 13(1 Pt 1) 38-42
35 Glanville A R, Gencay M, Tamm M et al.. Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant. 2005; 24 131-136
36 Rizzo M, Alevy Y G, Sundaresan S et al.. Increased expression of HDJ-2 (heat shock protein 40) and heat shock protein 70 in biopsy specimens of transplanted human lungs. J Heart Lung Transplant. 1998; 17 241-249
37 Stephenson A, Flint J, English J et al.. Interpretation of transbronchial lung biopsies from lung transplant recipients: inter- and intraobserver agreement. Can Respir J. 2005; 12 75-77
38 Colombat M, Groussard O, Lautrette A et al.. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. clinicopathologic correlations during the first 6 months after lung transplantation. Hum Pathol. 2005; 36 387-394
39 Yousem S A, Berry G J, Cagle P T et al.. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996; 15(1 Pt 1) 1-15
40 Girgis R E, Tu I, Berry G J et al.. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 1996; 15 1200-1208
41 Husain A N, Siddiqui M T, Montoya A, Chandrasekhar A J, Garrity E R. Post-lung transplant biopsies: an 8-year Loyola experience. Mod Pathol. 1996; 9 126-132
42 Tazelaar H D, Prop J, Nieuwenhuis P, Billingham M E, Wildevuur C R. Airway pathology in the transplanted rat lung. Transplantation. 1988; 45 864-869
43 Yousem S A, Dauber J A, Keenan R, Paradis I L, Zeevi A, Griffith B P. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans?. Transplantation. 1991; 52 306-309
44 Yousem S A. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol. 1993; 17 491-496
45 Husain A N, Siddiqui M T, Holmes E W et al.. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 1999; 159 829-833
46 Aboyoun C L, Hopkins P MA, Chhajed P N et al.. Lymphocytic bronchiolitis on transbronchial lung biopsy in lung transplant recipients: the persisting nemesis. J Heart Lung Transplant. 2002; 21 107
47 Ross D J, Marchevsky A, Kramer M, Kass R M. “Refractoriness” of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J Heart Lung Transplant. 1997; 16 832-838
48 Tamm M, Sharples L D, Higenbottam T W, Stewart S, Wallwork J. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. Am J Respir Crit Care Med. 1997; 155 1705-1710
49 Chakinala M M, Ritter J, Gage B F et al.. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant. 2004; 23 1396-1404
50 Valentine V G, Taylor D E, Dhillon G S et al.. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant. 2002; 21 319-326
51 Hopkins P M, Aboyoun C L, Chhajed P N et al.. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med. 2004; 170 1022-1026
52 Yousem S A. Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. Hum Pathol. 1996; 27 269-273
53 Schulman L L, Weinberg A D, McGregor C C, Suciu-Foca N M, Itescu S. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med. 2001; 163 437-442
54 Clelland C, Higenbottam T, Otulana B et al.. Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Transplant. 1990; 9(3 Pt 1) 177-185 discussion 185-186
55 Khalifah A P, Hachem R R, Chakinala M M et al.. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant. 2005; 5 2022-2030
56 Hachem R R, Khalifah A P, Chakinala M M et al.. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005; 80 1406-1413
57 Sibley R K, Berry G J, Tazelaar H D et al.. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant. 1993; 12 308-324
58 Boehler A, Vogt P, Zollinger A, Weder W, Speich R. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Eur Respir J. 1996; 9 658-662

Allan R GlanvilleM.D. F.R.A.C.P.

The Lung Transplant Unit, Xavier 4, St. Vincent's Hospital, Victoria St., Darlinghurst, Sydney

NSW 2010, Australia

eMail: aglanville@stvincents.com.au